A detailed history of Sg Americas Securities, LLC transactions in Cardiff Oncology, Inc. stock. As of the latest transaction made, Sg Americas Securities, LLC holds 23,937 shares of CRDF stock, worth $97,423. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,937
Holding current value
$97,423
% of portfolio
0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 03, 2024

BUY
$2.05 - $2.77 $49,070 - $66,305
23,937 New
23,937 $64,000
Q2 2022

Jul 29, 2022

SELL
$1.17 - $2.61 $45,270 - $100,988
-38,693 Closed
0 $0
Q1 2022

Apr 29, 2022

BUY
$2.11 - $7.25 $5,066 - $17,407
2,401 Added 6.62%
38,693 $96,000
Q4 2021

Feb 07, 2022

SELL
$5.18 - $7.24 $82,703 - $115,593
-15,966 Reduced 30.55%
36,292 $218,000
Q3 2021

Nov 01, 2021

BUY
$5.01 - $7.58 $261,812 - $396,115
52,258 New
52,258 $348,000

Others Institutions Holding CRDF

About Cardiff Oncology, Inc.


  • Ticker CRDF
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,334,900
  • Market Cap $176M
  • Description
  • Cardiff Oncology, Inc., a clinical-stage oncology company, develops medicine treatment for cancer patients in California. Its lead drug candidate is onvansertib, an oral selective Polo-like Kinase 1 Inhibitor for anti-cancer therapeutics; CY140, an inhibitor of PLK1, PLK2, and PLK3 that is in phase 1/2 studies in solid tumors and leukemias; meta...
More about CRDF
Track This Portfolio

Track Sg Americas Securities, LLC Portfolio

Follow Sg Americas Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sg Americas Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sg Americas Securities, LLC with notifications on news.